Go Pro
NYSEAMERICAN:GMO

General Moly (GMO) Stock Price, News & Analysis

General Moly logo

About General Moly Stock (NYSEAMERICAN:GMO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10,000 shs
Average Volume
871,865 shs
Market Capitalization
$17.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

General Moly, Inc. (NYSE American: GMO) is a U.S.–based mineral exploration and development company specializing in molybdenum. The company’s primary focus is advancing its flagship Mt. Hope project, one of the world’s largest undeveloped molybdenum deposits. Molybdenum is a key alloying element used to strengthen steel, enhance corrosion resistance and support emerging clean-energy technologies.

The Mt. Hope deposit, located in central Nevada, was originally discovered by AMAX in the 1970s and later passed through the portfolios of Cyprus Amax and Phelps Dodge. General Moly acquired the project in 2007 and has since completed extensive drilling campaigns, feasibility studies and environmental reviews. The company secured key federal and state permits in 2011 and has been optimizing mine design and processing flowsheets to support an open-pit mine and concentrator facility.

General Moly’s development plan envisions a crushing, grinding and flotation processing circuit capable of producing high-grade molybdenum concentrate for steelmakers, oil and gas catalyst producers, and specialty chemical manufacturers. The company continues to refine capital and operating cost estimates as it engages with equipment vendors and engineering firms to finalize detailed engineering and procurement packages.

Headquartered in Colorado, General Moly combines an in-house technical team of geologists, engineers and environmental specialists with external consultants to advance Mt. Hope toward production readiness. The company maintains active outreach with local Nevada communities and regulatory agencies and is pursuing offtake discussions with potential concentrate purchasers in North America and Asia.

AI Generated. May Contain Errors.

Receive GMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for General Moly and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GMO Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
GMO Mutual Funds
See More Headlines

GMO Stock Analysis - Frequently Asked Questions

General Moly, Inc. (NYSEAMERICAN:GMO) posted its quarterly earnings results on Tuesday, May, 8th. The basic materials company reported ($0.02) earnings per share for the quarter.

Shares of GMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that General Moly investors own include Avino Silver & Gold Mines (ASM), Ampio Pharmaceuticals (AMPE), Great Panther Mining (GPL), Alto Ingredients (PEIX), Actinium Pharmaceuticals (ATNM) and Evoke Pharma (EVOK).

Company Calendar

Last Earnings
5/08/2018
Today
9/01/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Materials
Industry
Metals & Mining
Sub-Industry
Diversified Metals & Mining
Current Symbol
NYSEAMERICAN:GMO
Previous Symbol
NYSEMKT:GMO
CIK
1275229
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
152,930,000
Free Float
N/A
Market Cap
$17.13 million
Optionable
Not Optionable
Beta
N/A
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSEAMERICAN:GMO) was last updated on 9/1/2026 by MarketBeat.com Staff.
From Our Partners